novo nordisk's wegovy reduces cardiovascular risk more than lilly's tirzepatide weight-loss drug may preserve lean body mass better Lilly's, study finds Novo Nordisk is slashing GLP-1

The most frequently reported NAEs included dizziness (n = 7,078), tremor (n = 2,519), dysgeusia (n = 1,469), lethargy (n = 783), taste disorder (n = 482), presyncope (n = 370), allodynia (n = 192), and parosmia (n = 192) (Fig

Some patients may receive higher or lower doses than prescribed

Many patients report feeling satisfied with smaller portions and experiencing fewer cravings, particularly for high-calorie foods

Tirzepatide thus offers unmatched effectiveness in terms of glycemic control and body weight reduction, as a report in Cardiovascular Diabetology noted

A Tirzepatide consultation, when performed in our offices, typically takes around 15 to 30 minutes and can be completed during your lunch break